ACARIX Acarix AB

Acarix publishes the annual report for 2021

Acarix publishes the annual report for 2021

Press release 

Malmö, Sweden, April 20, 2022  

Acarix publishes the annual report for 2021

Today, Wednesday April 20, Acarix is publishing its Annual Report for 2021 on the company website . An English translation of the annual report will be available on the company's website no later than 29 April.

   

For more information contact: 

Helen Ljungdahl Round, CEO, phone ,  

The information was provided, through the agency of the above contact person, for publication at the time specified by the company's news distributor, GlobeNewswire.

About Acarix: 

Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor®System calculates a patient-specific CAD-score non-invasively in less than 10 minutes and can help rule out more than one third of patients with at least 96% certainty (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, ) is Certified Advisor of Acarix. For more information, please visit 

Attachment



EN
20/04/2022

Underlying

ACARIXAcarix AB

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acarix AB

Free Trial
ACARIX ACARIX AB

Acarix AB: 1 director

A director at Acarix AB maiden bought 2,000,600 shares at 0.031USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

09/12/24 September 12, 2024 1 EN
 PRESS RELEASE
Free
ACARIX ACARIX AB

Acarix partners with Strategic Health AK to roll-out CADScor®System ac...

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Acarix continues its US expansion by partnering with Strategic Health AK, a healthcare provider covering tribal and rural areas of Alaska. Acarix has received initial orders of CADScor®Systems to be used across health regions in Alaska. Providing health care to remote populations in Alaska is challenging, and cardiac care is no different. Alaskan natives h...

June 22, 2022 1 EN
 PRESS RELEASE
Free
ACARIX ACARIX AB

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa C...

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska Pressmeddelande Malmö, 22 juni, 2022  Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska Acarix fortsätter sin USA-expansion genom ett samarbetsavtal med Strategic Health AK, en Alaska-baserad vårdgivare med särskilt fokus på Alaskas ursprungsbefolkning och patienter i landsbygdsområden. Acarix har erhållit initiala beställningar av CADScor®System som ska användas inom vårdregioner i Alaska. Att tillhandahålla hälsovård till avlägsna befolkningar i Ala...

June 22, 2022 1 EN
 PRESS RELEASE
Free
ACARIX ACARIX AB

Acarix signs additional commercial agreement in US and receives order ...

Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana. Press release Malmö, Sweden, June 10, 2022   Acarix signs additional commercial agreement in US and receives order for CADScor®System in Louisiana. Acarix continues the US expansion with another commercial partnership now covering Louisiana and parts of Mississippi. This partnership with Bio-Rhythms Inc provides access to cardiology clinics, emergency departments and primary care clinics in geographic areas with high medical need for rapid and cost-effective rule-out of coronary artery d...

June 10, 2022 1 EN
 PRESS RELEASE
Free
ACARIX ACARIX AB

Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller bestä...

Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller beställning på CADScor®System i Louisiana. Pressmeddelande Malmö, 10 juni, 2022   Acarix tecknar ytterligare kommersiellt avtal i USA och erhåller beställning på CADScor®System i Louisiana. Acarix fortsätter att utöka täckningen i USA genom ytterligare ett kommersiellt partnerskap som täcker Louisiana och delar av Mississippi. Detta partnerskap med Bio-Rhythms Inc ger tillgång till kardiologiska mottagningar, akutmottagningar och primärvårdsmottagningar i geografiska områden med höga medicinska behov för snabb och kostnads...

June 10, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch